Echo Investment Capital

Founded in 2020 by Jesse McCool in Oklahoma City, Wheeler Bio is a biomanufacturing company dedicated to expediting the translation of therapeutic innovations into clinical impact. It offers comprehensive discovery-to-IND programs and rapid, portable CMC platforms, bridging critical gaps between discovery and early development.

Talus Network is a pioneering blockchain-based platform that seeks to democratize artificial intelligence. It develops a decentralized system that merges blockchain technology with autonomous AI agents, fostering consumer-friendly on-chain AI applications, notably smart agents. These agents seamlessly integrate into everyday on-chain content, empowering developers to create more secure, transparent, and efficient decentralized, autonomous systems.

Antheia is a biotechnology company focused on harnessing the medicinal power of nature through innovative manufacturing processes. The company employs synthetic biology to overcome traditional drug manufacturing limitations by reconstructing complex molecules in yeast, eliminating the need for medicinal plants. This approach ensures reliable, consistent, and widespread availability of essential medicines. Antheia's methods transform the pharmaceutical supply chain, offering cost-competitive, plant-based medicines that provide healthcare organizations with natural and healthier medication options.

TARA Mind is a company dedicated to improving mental health outcomes by closing gaps in therapeutic accessibility and affordability for high-risk individuals. It offers employers a supplemental benefit that provides safe, affordable access to life-changing mental health therapies, focusing on treatment-resistant depression.

DEKA Biosciences is an early-stage biotechnology company focused on developing next-generation cytokine therapeutics aimed at treating cancer and inflammatory diseases. The company creates therapies with disease-specific applications that enhance patient outcomes by optimizing pharmacokinetics and pharmacodynamics through the targeted delivery of dual and complementary cytokines to affected tissues or cells. This innovative approach seeks to provide patients with curative treatment options for various conditions, including cancer, autoimmune disorders, and infectious diseases.

Founded in 2020 by Jesse McCool in Oklahoma City, Wheeler Bio is a biomanufacturing company dedicated to expediting the translation of therapeutic innovations into clinical impact. It offers comprehensive discovery-to-IND programs and rapid, portable CMC platforms, bridging critical gaps between discovery and early development.

Founded in 2020 by Jesse McCool in Oklahoma City, Wheeler Bio is a biomanufacturing company dedicated to expediting the translation of therapeutic innovations into clinical impact. It offers comprehensive discovery-to-IND programs and rapid, portable CMC platforms, bridging critical gaps between discovery and early development.

TESSA is an investment platform that enables fractional ownership and trading of high-value artwork represented as digital certificates on a public blockchain. It allows micro-collectors to acquire, transfer, and exchange fractions of blue-chip works, providing liquidity similar to public markets. The platform handles maintenance and administration for the artworks and promotes them to broaden exposure. It offers transparent records of ownership certificates, transaction history, and transfers through a blockchain network and trusted third-party providers, with the goal of improving accessibility to the art market and enhancing value through curated collections.

DEKA Biosciences is an early-stage biotechnology company focused on developing next-generation cytokine therapeutics aimed at treating cancer and inflammatory diseases. The company creates therapies with disease-specific applications that enhance patient outcomes by optimizing pharmacokinetics and pharmacodynamics through the targeted delivery of dual and complementary cytokines to affected tissues or cells. This innovative approach seeks to provide patients with curative treatment options for various conditions, including cancer, autoimmune disorders, and infectious diseases.

Founded in 2020 by Jesse McCool in Oklahoma City, Wheeler Bio is a biomanufacturing company dedicated to expediting the translation of therapeutic innovations into clinical impact. It offers comprehensive discovery-to-IND programs and rapid, portable CMC platforms, bridging critical gaps between discovery and early development.

Zeno, based in Oklahoma and Austin, operates a cloud-based platform tailored for energy companies, investors, and partners seeking to navigate the evolving market landscape. The company focuses on enhancing business performance by unlocking data and offering real-time insights that enable informed decision-making. Zeno's Energy Operating System connects various aspects of an organization, automating repetitive tasks and providing clarity to improve operational efficiency. By equipping energy-focused organizations with modern tools, Zeno aims to facilitate the identification and pursuit of new investment opportunities, ultimately contributing to a more data-driven and sustainable future in the energy sector.